Literature DB >> 11012591

Chemotherapy-induced acral erythema: report of a case and immunohistochemical findings.

D Tsuruta1, K Mochida, T Hamada, M Ishii, K Wakasa, S Hashimoto, K E Takekawa.   

Abstract

Chemotherapy-induced acral erythema (CAE) is an uncommon and distinct reaction seen in patients receiving high-dose chemotherapy. The exact pathogenic mechanisms of this disorder are still unknown. We report a 27-year-old woman who presented with red, swollen and painful macules on both palms, clinically consistent with this disease. Histological examination demonstrated vacuolar degeneration of the basal cell layer and spongiotic blisters in the epidermis, especially in the atrophied eccrine ducts and papillary oedema with mild perivascular infiltration of mononuclear and hypersegmented neutrophils. Immunohistochemistry showed that the infiltrating mononuclear cells were CD3-CD16+CD56+ leucocyte function antigen-1+, possibly natural killer cells. The eccrine ducts expressed HLA-DR and intracellular adhesion molecule-1 (ICAM-1). Our findings suggest that cell-to-cell interaction between NK cells and keratinocytes in the eccrine apparatus may induce CAE and may be involved in the pathogenesis of the skin reaction in our patient and possibly in this disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11012591     DOI: 10.1046/j.1365-2230.2000.00670.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  3 in total

1.  Novel role of regulatory T cells in limiting early neutrophil responses in skin.

Authors:  Hannah Richards; Anwen Williams; Emma Jones; James Hindley; Andrew Godkin; Anna Katharina Simon; Awen Gallimore
Journal:  Immunology       Date:  2010-08-17       Impact factor: 7.397

2.  Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5.

Authors:  Sherry L Wolf; Rui Qin; Smitha P Menon; Kendrith M Rowland; Sachdev Thomas; Robert Delaune; Diana Christian; Eduardo R Pajon; Daniel V Satele; Jeffrey L Berenberg; Charles L Loprinzi
Journal:  J Clin Oncol       Date:  2010-11-08       Impact factor: 44.544

3.  Cutaneous toxicity of oral low-dose methotrexate.

Authors:  Priyanka Jalandhara; Gurjit Kaeley
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-05-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.